雅培（上海）诊断产品销售有限公司
- Company typePrivate
- Founded-
- HeadquartersShanghai, China
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
雅培（上海）诊断产品销售有限公司 firmographics
Firmographics- Name
- 雅培（上海）诊断产品销售有限公司
- Legal name
- 雅培（上海）诊断产品销售有限公司
- Website
- https://alerechina.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where 雅培（上海）诊断产品销售有限公司 is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
雅培（上海）诊断产品销售有限公司 business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D
Revenue model
- Rapid Point-of-Care Diagnostic Instruments: Sale of diagnostic analyzers and test systems including Afinion 2, Determine, BinaxNOW, and i-STAT for use in healthcare settings at point of care.
- Diagnostic Test Reagents and Consumables: Recurring revenue from sale of test cartridges, reagents, and consumables for the diagnostic platforms. Testing reagents for HIV, influenza, cardiovascular markers, and other conditions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
雅培（上海）诊断产品销售有限公司 product offering
Product offeringCore offering
The company sells and distributes Abbott's rapid point-of-care diagnostic instruments and consumables (Afinion 2 Analyzer, Determine HIV Early Detect, BinaxNOW Influenza A & B Card, Afinion CRP) to healthcare institutions in China. The portfolio enables bedside testing with results in minutes using fingertip blood or swab samples, eliminating the need to send samples to a central laboratory. It is the Chinese commercial entity for Abbott's Global Point of Care diagnostics division, supporting cardiovascular, infectious disease, and chronic disease testing at the point of care.
Product overview
雅培（上海）诊断产品销售有限公司提供以 Afinion™ 2 系统为核心的快速床旁诊断产品组合。该组合包括 Afinion 2 分析仪（多项测定分析仪，提供 HbA1c、ACR、CRP 和血脂检测）、Afinion CRP（独立 CRP 检测模块）、Determine HIV Early Detect（HIV 早期检测）以及 BinaxNOW 甲乙型流感试剂卡。产品组合通过指尖采血或拭子样本实现即时诊断，无需将样本送至实验室，可在数分钟内提供检测结果，支持心血管疾病早筛、感染病诊断等应用场景。
Differentiator
Problem solved
Functional benefit
Brands
- Afinion: Rapid point-of-care testing system for HbA1c, ACR, CRP, and lipid panels
- Determine
- BinaxNOW
Products and services
- Afinion 2 Analyzer (Afinion 2 系统)
Quantifiable outcome
- Results available within minutes during consultation rather than days for laboratory testing
- +2 more outcomes
Companies that use 雅培（上海）诊断产品销售有限公司
Customer profileSegments3 records
Ideal customer profiles1 record
雅培（上海）诊断产品销售有限公司 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
雅培（上海）诊断产品销售有限公司 partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights3 records
雅培（上海）诊断产品销售有限公司 competitors and assessment
Company assessmentDirect peers
- Roche Diagnostics: Roche Diagnostics is the largest global IVD player and Abbott's main peer in rapid point-of-care diagnostics, with POC platforms (e.g., cobas Liat) spanning infectious disease, cardiac, and metabolic testing in hospitals and clinics in China.
- BD (Becton, Dickinson and Company): BD competes directly with Abbott in rapid POC infectious disease and chronic disease diagnostics via its BD Veritor System, addressing similar hospitals, clinics, and physician office customers in China.
- Sysmex Corporation: Sysmex is a global IVD leader with a strong presence in hematology and POC diagnostics in Asia, competing with Abbott POC systems for clinical diagnostics business in Chinese hospitals and reference labs.
- Cepheid (Danaher): Cepheid's GeneXpert molecular POC system competes with Abbott's i-STAT and Determine rapid tests at the point of care, particularly for infectious disease testing in Chinese hospital and clinic settings.
- bioMérieux: bioMérieux is a leading microbiology and infectious disease diagnostics company whose VITEK, BioFire, and rapid test portfolios overlap with Abbott's infectious disease POC offerings distributed in China.
- QuidelOrtho: QuidelOrtho's Sofia and Triage rapid diagnostic platforms directly rival Abbott's BinaxNOW influenza and Afinion cardiac/metabolic assays in clinical POC settings, including the Chinese market.
Regional players
- Mindray Bio-Medical Electronics: Mindray is one of China's largest medical device companies with growing POC and in-vitro diagnostic offerings that increasingly compete with Abbott's rapid diagnostic portfolio in Chinese hospitals.
- Wondfo Biotech: Wondfo is a leading Chinese POCT diagnostics company offering lower-priced rapid tests for infectious disease, fertility, and chronic conditions, directly competing with Abbott POC products in the Chinese market.
- Sinocare Inc. Sinocare is a major Chinese diagnostic devices company with strong positions in blood glucose monitoring and other chronic disease POC tests, competing with Abbott's Afinion platform in Chinese clinics.
Broad incumbents
- Siemens Healthineers: Siemens Healthineers is a broad incumbent in diagnostics and medical devices with POC offerings (epoc, RAPIDPoint) that compete with Abbott's POC blood gas and chemistry analyzers in Chinese healthcare institutions.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
雅培（上海）诊断产品销售有限公司 social profiles
Digital presence雅培（上海）诊断产品销售有限公司 compliance and trust
Trust signalCompliance1 record
雅培（上海）诊断产品销售有限公司 financial estimates
Financial estimateRevenue estimate
Valuation estimate
雅培（上海）诊断产品销售有限公司 leadership team
Management profileNumber of profiles
Profiles1 record
雅培（上海）诊断产品销售有限公司 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
雅培（上海）诊断产品销售有限公司 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 雅培（上海）诊断产品销售有限公司
What does 雅培（上海）诊断产品销售有限公司 do?
The company sells and distributes Abbott's rapid point-of-care diagnostic instruments and consumables (Afinion 2 Analyzer, Determine HIV Early Detect, BinaxNOW Influenza A & B Card, Afinion CRP) to healthcare institutions in China. The portfolio enables bedside testing with results in minutes using fingertip blood or swab samples, eliminating the need to send samples to a central laboratory. It is the Chinese commercial entity for Abbott's Global Point of Care diagnostics division, supporting cardiovascular, infectious disease, and chronic disease testing at the point of care.
Is 雅培（上海）诊断产品销售有限公司 a public or private company?
雅培（上海）诊断产品销售有限公司 is a private company. It is classified as corporate owned and is currently operating.
When was 雅培（上海）诊断产品销售有限公司 founded?
雅培（上海）诊断产品销售有限公司 was founded in -1. It employs 1 to 10 people.
Where is 雅培（上海）诊断产品销售有限公司 based?
雅培（上海）诊断产品销售有限公司 is headquartered in Shanghai, China, in the Asia region.
How does 雅培（上海）诊断产品销售有限公司 make money?
Two revenue lines are on record. Rapid Point-of-Care Diagnostic Instruments are the primary driver. The others are diagnostic Test Reagents and Consumables.
Who are 雅培（上海）诊断产品销售有限公司's main competitors?
Direct peers on record are Roche Diagnostics, BD (Becton, Dickinson and Company), Sysmex Corporation, Cepheid (Danaher), bioMérieux and QuidelOrtho. Regional players are Mindray Bio-Medical Electronics, Wondfo Biotech and Sinocare Inc.. Siemens Healthineers is listed as a broad incumbent.
Does 雅培（上海）诊断产品销售有限公司 have an API?
No public API is recorded for 雅培（上海）诊断产品销售有限公司.